FOLD
Amicus Therapeutics·NASDAQ
--
--(--)
--
--(--)
FOLD fundamentals
Amicus Therapeutics (FOLD) Revenue Breakdown: Q3 2025 Business & Regional Performance
Amicus Therapeutics (FOLD) reported total revenue of 169.06M USD in Q3 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 41.56% of total revenue. Explore Amicus Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Amicus Therapeutics (FOLD) reported total revenue of 169.06M USD in Q3 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 41.56% of total revenue. Explore Amicus Therapeutics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Amicus Therapeutics's earnings call?What is Amicus Therapeutics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Amicus Therapeutics year over year?What guidance did Amicus Therapeutics's management provide for the next earnings period?What factors drove the changes in Amicus Therapeutics's revenue and profit?What does Amicus Therapeutics do and what are its main business segments?What is the market's earnings forecast for Amicus Therapeutics next quarter?Did Amicus Therapeutics beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
